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Osmotic homeostasis in the brain involves movement of water
through aquaporin-4 (AQP4) membrane channels. Perivascular
astrocyte end-feet contain distinctive orthogonal lattices (square
arrays) assembled from 4- to 6-nm intramembrane particles (IMPs)
corresponding to individual AQP4 tetramers. Two isoforms of
AQP4 result from translation initiation at methionine residues M1
and M23, but no functional differences are known. In this study,
Chinese hamster ovary cells were transfected with M1, M23, or
M1M23 isoforms, and AQP4 expression was confirmed by immu-
noblotting, immunocytochemistry, and immunogold labeling.
Square array organization was examined by freeze–fracture elec-
tron microscopy. In astrocyte end-feet, >90% of 4- to 6-nm IMPs
were found in square arrays, with 65% in arrays of 13–30 IMPs. In
cells transfected with M23, 95% of 4- to 6-nm IMPs were in large
assemblies (rafts), 85% of which contained >100 IMPs. However,
in M1 cells, >95% of 4- to 6-nm IMPs were present as singlets, with
<5% in incipient arrays of 2–12 IMPs. In M1M23 cells, 4- to 6-nm
IMPs were in arrays of intermediate sizes, resembling square arrays
in astrocytes. Structural cross-bridges of 1  2 nm linked >90% of
IMPs in M23 arrays (1,000 cross-bridges per m2) but were rarely
seen in M1 cells. These studies show that M23 and M1 isoforms
have opposing effects on intramembrane organization of AQP4:
M23 forms large square arrays with abundant cross-bridges; M1
restricts square array assembly.
Aquaporins are specialized water transport channels inplasma membranes of water-permeable tissues (1). Aqua-
porins 1 and 4 (AQP1 and AQP4) are most important to fluid
movements in mammalian brain. AQP4 exists as two isoforms,
differing at their N termini, because of translation initiation at
the first methionine (M1, 323 aa) or the second methionine
(M23, 301 aa) (2, 3). Both isoforms are present in brain, but M23
is at least 3-fold more abundant (4, 5). Endogenous AQP4 is a
tetramer usually containing M1 and M23 subunits. The water
permeabilities of M1 and M23 are similar, and functional
differences are not known (3, 4).
Fluid movements are precisely orchestrated within the rigid
cranium to prevent physical damage from swelling or shrinkage.
Interfaces between brain parenchyma and cerebrospinal f luid
occur around the ventricles, surrounding blood vessels, and at
the brain surface. AQP1 is expressed in rat choroid plexus, the
site of cerebrospinal f luid secretion (6), whereas AQP4 is
enriched in rat astrocyte end-feet surrounding brain capillaries
(7, 8). Astrocyte processes forming the glia limitans at brain
surfaces, ependymal cells lining brain ventricles, and Müller cells
facing the vitreous body and retinal blood vessels all have
abundant AQP4 (9). AQP4 in perivascular membranes of as-
trocyte end-feet has been implicated in neurological disorders,
including acute hyponatremic edema, postischemic injury, and
epileptic seizures (10–13).
Perivascular membranes of astrocyte end-feet contain numer-
ous strikingly regular arrays of intramembrane particles (IMPs)
in freeze–fracture electron micrographs. These IMP arrays have
been referred to as square arrays, assemblies, or orthogonally
arranged particles (OAPs) (14). In early freeze–fracture images
of astrocyte end-feet (15), square arrays were resolved as 6-nm
IMP protrusions in P-face images (protoplasmic leaflets) or as
smaller pits in E-faces (extraplasmic leaflets). The sizes and
shapes of square arrays vary, but the IMPs and pits have uniform
6-nm lattice spacings within arrays (Fig. 1). Square arrays were
observed in Chinese hamster ovary (CHO) cells transfected with
AQP4 (16, 17) but not in AQP4-null mice (18). Anti-AQP4
directly labeled square arrays in replicas of astrocyte end-feet
(19). The atomic structure of the homologous protein AQP1 has
a tetramer cross-sectional diameter of 6 nm (20), similar to the
4- to 6-nm IMPs.
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Fig. 1. Freeze–fractured astrocyte end-feet membranes in suprachiasmic
nucleus from adult rat. (A) The conventional replica has a 2-nm-thick platinum
coat and a 1- to 2-nm coat of water vapor (27). Multiple square arrays appear
as 6-nm P-face IMPs. (B) In higher-resolution replicas made with 1 nm of
platinum without detectable water vapor, square arrays consist of 4-nm IMPs
linked by 1  2 nm cross-bridges. (C) In E-face images, 3- to 4-nm pits are linked
by 1  2 nm furrows. (Insets) Representative examples are enlarged and
printed with black shadows. (Bars  100 nm.)








Here we report freeze–fracture analyses of AQP4 proteins
after stable transfection of CHO cells with M1, M23, or
M1M23 isoforms. M23 homotetramers produce large square
lattices with 1  2 nm inter-IMP cross-bridges, whereas M1
homotetramers produce dispersed 4- to 6-nm IMPs with few
incipient square arrays. When M1 and M23 are coexpressed to
form hetero- and homotetramers, square arrays are of interme-
diate sizes, similar to square arrays in astrocyte end-feet. These
studies demonstrate that regulation of the size of AQP4 arrays
occurs by interaction of the M1 and M23 isoforms of AQP4 and
provide a mechanism for regulating the organization of AQP4
arrays.
Materials and Methods
Plasmid Construction and Cell Lines. AQP4 expression constructs
were created by using pCI-neo (Promega) and cDNA for rat
AQP4 M1 or M23 (4), pIRESneo3 (Clontech) and cDNA for
M23, and pcDNA3.1Zeo (Invitrogen) and cDNA for M1.
CHO-K1 cells (American Type Culture Collection) were cul-
tured in 90% F12-K and 10% fetal bovine serum (Invitrogen).
Cells were transfected with AQP4 expression vectors, or empty
vector, by using Lipofectamine 2000 (Invitrogen) and the man-
ufacturer’s protocol; 10-cm2 dishes were cultured for 2 weeks in
1 mgml Geneticin (Invitrogen). Cells expressing M1M23 were
obtained from stable M23 cells (pIRESneo3) transfected with
pcDNA3.1Zeo-M1 and cultured for 2 weeks in 1 mgml
Geneticin and 500 gml Zeocin (Invitrogen). Stable expression
of M1 and M23 was confirmed by immunoblotting with anti-
AQP4 (Chemicon) at 2 gml.
Antibodies and Immunogold Labels. Affinity-purified antibodies to
the C terminus of rat AQP4 (anti-CT) were from Søren Nielsen
(University of Aarhus, Aarhus, Denmark) (21) or Chemicon;
affinity-purified antibodies raised to the N terminus of rat AQP4
(anti-NT) were reported (4). Goat anti-rabbit IgG antibodies
conjugated to 10-nm gold beads were from British Biocell
International (Cardiff, U.K.) and Chemicon, and 12-nm gold
beads (goat anti-rabbit IgG) were from Jackson ImmunoRe-
search.
Fluorescence Microscopy and Biochemical Studies. Transfected CHO
cells grown on Lab-Tek Permanox chamber slides (Nalge Nunc)
were fixed in PBS with 4% formaldehyde, permeabilized in 0.5%
Triton X-100, blocked in 1% BSA, and incubated with AQP4
antibody (Chemicon) at 0.5 gml in blocking solution, followed
by Alexa-488-conjugated goat anti-rabbit IgG secondary anti-
body (Molecular Probes) diluted to 2 gml in blocking solution.
Confocal microscopy used an UltraView LCI (Perkin–Elmer) on
a Zeiss Axiovert 200.
For immunoprecipitations, CHO cells expressing M23, M1, or
M1M23 were solubilized in solubilization buffer [200 mM
NaCl20 mM TrisHCl, pH 81% Triton X-1001% sodium
deoxycholate0.1% SDS plus protease inhibitors (Complete
mixture tablets, Roche Diagnostics)] and incubated with 3 gml
anti-NT for 1 hr on ice. Immune complexes were concentrated
by using protein A-Sepharose (Sigma), immunoblotted, and
probed with anti-CT. For surface biotinylation assays, cells were
rinsed in PBS, incubated in 0.5 mgml Sulfo-NHS-LC-Biotin
(Pierce) on ice for 30 min, washed with 50 mM TrisHCl, pH 8.0,
for 5 min, rinsed twice with ice-cold PBS, and resuspended in
solubilization buffer. After centrifugation for 5 min at 14,000 
g, 1 ml of supernatant was mixed with 200 l of agarose-
immobilized streptavidin (Pierce) and incubated at 4°C over-
night. The beads were washed three times in solubilization buffer
and eluted with 50 l of Laemmli loading buffer (3% SDS10
mM TrisHCl, pH 6.810% glycerol0.2% bromophenol blue)
for 30 min at 37°C. Biotinylated AQP4 was visualized by
immunoblotting 12 l of eluate and probing with anti-CT (2
gml). Immunoblots were stripped and reprobed with anti-
actin (1:10,000, Sigma).
Freeze Fracture and Electron Microscopy. Rat tissues were fixed by
transcardiac perfusion with 2% glutaraldehyde in 140 mM
Sorensen’s phosphate buffer (SPB), pH 7.4, and 150-m sections
were prepared from the suprachiasmatic nucleus by using a
refrigerated Lancer 1000 Vibratome. CHO cells for freeze
fracture were pelleted and fixed in 2.5% glutaraldehyde. CHO
cells for immunolabeling were immersion-fixed in 1% formal-
dehyde (22) in SPB for 10 min, rinsed, and stored up to 48 hr in
SPB. Tissue sections and CHO cells were infiltrated with 30%
glycerol, frozen (23), fractured, and replicated in a JEOL
RFD-9010C freeze–fracture device with high-resolution shad-
owing methods revealing details 1 nm in nonaveraged images
(24). Samples fractured at 170°C, precoated with 0.8- to 1-nm
carbon were shadowed with 1–1.5 nm of platinum at a 60° angle
(25). After freeze fracture, samples were bonded in Lexan plastic
to gold index grids (22), thawed, photomapped, and cleaned in
chromicsulfuric acid. For freeze–fracture immunolabeling,
Fig. 2. Expression of M1 and M23 isoforms of AQP4 in stably transfected CHO
cells. (A) Confocal AQP4 immunofluorescence of cells transfected with M1,
M23, M1M23, or control (empty vector) incubated with anti-CT (reacts with
M1 and M23). (100.) (B Upper) Anti-CT immunoblot of membrane proteins
prepared from rat cerebellum or transfected CHO cells (10 g of protein per
lane). (Lower) Solubilized cell lysate immunoprecipitated with anti-NT (spe-
cific for N terminus of M1) analyzed by anti-CT immunoblot. (C) Biochemical
demonstration of M1 and M23 at the cell surface. Cells were treated with a
membrane-impermeant biotinylating agent, precipitated by streptavidin
(SA), and analyzed by anti-CT or anti-actin immunoblot (see Materials and
Methods).
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samples were cleaned with 2.5% SDS before immunogold la-
beling (22, 26, 27).
A JEOL 2000 EX-II transmission electron microscope was
used. Images at 30,000 to 150,000 magnification were digi-
tized by ArtixScan 2500 digital scanning (Microtek International,
Carson, CA), and processed with PHOTOSHOP (Adobe Systems,
San Jose, CA). Seven sets with 42 replicates of 29 blinded
samples were photographed before decoding. Freeze–fracture
images were examined from 30 untransfected control CHO cells
(3 replicates), 40 vector-transfected cells (4 replicates), 150
M1-transfected cells (10 replicates), 30 M23-transfected cells (3
replicates), and 30 cells transfected with M1 and M23 (3
replicates).
Results
Expression of AQP4 M1 and M23 Isoforms. Stably transfected CHO
cells were evaluated by confocal immunofluorescence micros-
copy (5). More than 95% of cells transfected with M1, M23, or
M1M23 exhibited plasma membrane immunofluorescence.
Cells transfected with empty vector exhibited no detectable
plasma membrane staining (Fig. 2A). Background staining with
anti-NT prevented its use in immunofluorescence. Expression of
AQP4 isoforms in transfected cells was compared with endog-
enous AQP4 expression in rat cerebellum by immunoblotting
(Fig. 2B Upper). Anti-CT revealed a 34-kDa band in membranes
from M1 cells, a 32-kDa band in M23 cells, and both bands in
M1M23 cells. Immunoprecipitation with anti-NT followed by
immunoblotting with anti-CT confirmed that M1 and M23
are associated within AQP4 heterotetramers in M1M23 cells
(Fig. 2B Lower). Surface expression of M1 and M23 was
confirmed by surface biotinylation and precipitation with
streptavidin (Fig. 2C).
Freeze–Fracture Studies. Freeze–fracture analysis of untransfected
control CHO cells revealed 7- to 9-nm IMPs at 2,000 per m2 in
P-faces (Fig. 3A) and 7- to 9-nm pits at 500 per m2 in E-faces
(Fig. 3B). Neither square arrays nor 4- to 6-nm IMPs or pits were
observed.
Freeze–fracture images of CHO cells stably transfected with
M23 had large, raft-like square arrays with uniform lattice
spacings of 6 nm. At 3–5 rafts per m2, these arrays varied in size
but generally contained 100 P-face IMPs (Fig. 3 C and D) or
E-face pits (Fig. 3E). Many of these rafts appeared to be formed
from side-to-side association of smaller square arrays. AQP4
protein was confirmed in M23 rafts by immunogold labeling with
anti-CT multiple immunogold beads (Fig. 3D). The largest rafts
were labeled by up to 20 immunogold beads (not shown).
Immunogold beads were rarely observed over other areas of
plasma membrane, suggesting that M23 polypeptides exist pre-
dominantly within square arrays.
Freeze–fracture analysis of M1 cells revealed 4- to 6-nm P-face
IMPs or E-face pits dispersed primarily as singlets (see below)
and were increased by 550 per m2. In a third of M1 cells, up to
5% of IMPs or pits were found in incipient square arrays
consisting of 2–12 IMPs or pits (Fig. 4). When present, square
arrays in M1 cells were much smaller than rafts in M23 cells or
square arrays in astrocyte end-feet. Immunogold labeling of
P-faces in M1 was above background but could not be uniquely
associated with any IMP or IMP cluster (not shown).
Four populations of M1M23 cells were observed. Only
10% of cells had no detectable square arrays (not shown),
whereas 10% of cells contained abundant 4- to 6-nm IMPs and
rudimentary square arrays composed of 2–8 IMPs or pits (Fig.
5A). Most cells coexpressing M1 and M23 contained 20–50
square arrays per m2 (Fig. 5B), with 4–24 IMPs or pits per
Fig. 3. Freeze–fractured control CHO cells and cells expressing M23. (A and B) P-face (A) and E-face (B) images of cells transfected with empty vector reveal
P-face IMPs and E-face pits of 7- to 9-nm diameter but no square arrays. No 4- to 6-nm-diameter pits were detected. E-faces have fewer IMPs than P-faces (A).
(C) P-face image of M23 cell reveals three square arrays (small ovals) and five large rafts, all with 6-nm spacing (large ovals). (D) Anti-CT immunogold labeling
of rafts in P-face of M23 cell. (E) High magnification of E-face image of raft in M23 cell. D was from formaldehyde-fixed cells (24), but the other images were
from glutaraldehyde-fixed cells. Arrows denote direction of shadowing. (Bars  100 nm.)








array. Approximately 10% of cells had large rafts consisting of
dozens of IMPs or pits (Fig. 5C).
Morphometric Analyses of Square Arrays. Differences in square
array formation were quantified from high-magnification freez-
e–fracture images. The average assembly state of 4- to 6-nm
IMPs or pits was calculated by dividing total number of 4- to
6-nm IMPs or pits by the sum of the number of assemblies
(singlets  square arrays  large rafts). For technical reasons,
individual 4- to 6-nm IMPs or pits were difficult to count (28).
The number of IMPs or pits in different assembly states was
determined with bins corresponding to the following assembly
states (Fig. 6): singlets (isolated IMP or pit); incipient arrays
(2–12 IMPs or pits, M1 only); square arrays (2–12, 13–30, or
31–100 IMPs or pits); and rafts (100 IMPs or pits). In
astrocytes, the average array contained 17 IMPs or pits (ranging
up to 53). Arrays in M23 cells were larger, containing an average
of 78 IMPs or pits (up to 450), with 85% of 4- to 6-nm IMPs or
pits in large rafts, 10% in square arrays and small rafts, and 5%
as singlets. In contrast, 4- to 6-nm IMPs or pits in M1 cells were
predominantly dispersed as singlets, with the few incipient arrays
containing an average of 2 IMPs or pits (up to 12). M1M23
cells contained assemblies in a variety of states corresponding to
incipient arrays, square arrays, and rafts. M1M23 assemblies
contained an average of 6 IMPs or pits (up to 72), intermediate
between the values for M1 cells and M23 cells. Large areas (10
m2) were examined, but evidence did not suggest that mem-
brane domains had different distributions within a cell. The
images are representative from 1,000 micrographs (all sam-
ples).
Cross-Bridges and Furrows. Freeze–fracture analyses of astrocyte
end-feet revealed 1  2 nm cross-bridges connecting IMPs in
P-face images or furrows between pits in E-face images (Fig. 1
B and C). Because pits and furrows are less vulnerable to plastic
deformation, E-face images of astrocytes and transfected cells
were studied (Fig. 7). Technical limitations precluded firm
conclusions, but some differences were observed. Astrocyte
end-feet contained furrows between 60% of E-face pits (Fig.
7A). In contrast, furrows connected 90% of E-face pits (500
per m2) in M23 rafts (Fig. 7B). M1 cells contained very few
incipient arrays and their IMPspits were rarely linked by
cross-bridges or furrows (20 m2) (Fig. 7 C–E). Most IMPs or
pits in M1M23 cells were in square arrays, and 50% were
linked by furrows (Fig. 7F).
Fig. 4. Freeze–fracture images of cells expressing M1. (A and B) E-face (A)
and P-face (B) images reveal abundant 4- to 6-nm pits or IMPs and occasional
incipient square arrays with 12 pits or IMPs in square lattices with 6-nm
spacing (ovals). (C) E-face image of an occasional cell with a larger number of
incipient arrays (ovals) and singlet 4- to 6-nm pits (arrows). (Bars  100 nm.)
Fig. 5. Freeze–fracture images of cells expressing M1 and M23. (A and B)
P-face (A) and E-face (B) images reveal multiple small square arrays of up to 20
IMPs or pits in 6-nm spacing (ovals). (C) E-face of occasional cell with larger
square arrays of up to 100 pits (ovals). (Bars  100 nm.)
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Discussion
Astrocyte membrane end-feet have long been known to contain
strikingly regular square arrays when examined by freeze frac-
ture (14, 15). The arrays were reported to disassemble under
various metabolic and osmotic conditions (14, 29, 30) and may
vary with tissue preservation conditions and even between
adjacent astrocytes (24, 31). Because mechanisms regulating
AQP4 array assembly are unknown, we explored the possibility
that AQP4 isoforms M1 and M23 may be determinants.
Freeze fracture revealed major differences between CHO
cells stably transfected with M1 and M23 isoforms of AQP4. M23
cells contained large rafts, many with 10 times more 4- to 6-nm
IMPs or pits as square arrays in normal astrocyte end-feet (Figs.
1 and 3). The small number of large rafts suggests that M23
self-assembles into a highly stable configuration. In contrast,
cells expressing M1 contained dispersed 4- to 6-nm IMPs or pits
and a few incipient arrays in rudimentary square lattices (Fig. 4).
Although additional molecules may participate in AQP4 array
assembly, the remarkable differences in assembly appear to be
inherent properties of M23 and M1 polypeptides, because similar
morphologies were seen after both formaldehyde and glutaral-
dehyde fixation (Fig. 3 D vs. C). On the basis of lack of 4- to 6-nm
IMPs or pits in untransfected CHO cells (Fig. 3 A and B), their
appearance in arrays with 6-nm lattice spacing in M23 rafts (Fig.
3 C–E), and presence as dispersed singlets in M1 cells (Fig. 4),
we conclude that the 4- to 6-nm IMPs and pits represent
individual AQP4 tetramers. This conclusion is supported by
atomic structures of homologous proteins AQP1 (20, 32, 33) and
GlpF (34), with tetramer cross-sectional diameters of 6 nm. The
slightly smaller diameter of the replicated IMPs and pits may
reflect the diameter of each tetramer within the lipid bilayer.
Our study indicates that M1 tetramers directly interfere with
assembly of M23 tetramers into large arrays. Cross-bridges or
furrows linked nearly all 4- to 6-nm IMPs or pits in M23 cells, but
were rare in M1 cells (Fig. 7), suggesting that M1 and M23 differ
at the site of square array assembly. In contrast, cells cotrans-
fected with M1 and M23 had square arrays with a range of sizes,
often resembling arrays in astrocyte end-feet (Figs. 1 and 5).
Individual AQP4 tetramers in rat brain (4) and in CHO cells
transfected with M1 and M23 polypeptides were shown by
Fig. 6. Histogram of IMP or pit assembly state in membranes of astrocyte
end-feet and CHO cells expressing M23, M1, or M1M23. Morphometric
analyses of P-face and E-face images compiled the number of singlet 4- to
6-nm IMPs or pits, incipient arrays with 2–12 IMPs or pits (*, M1 only), square
arrays with 2–12, 13–30, and 31–100 IMPs or pits, and rafts with 100 IMPs or
pits. The survey compiled 4- to 6-nm IMPs or pits from astrocytes (1,832 IMPs,
0.52 m2), M23 cells (1,552 IMPs, 0.94 m2), M1 cells (252 IMPs, 0.46 m2), and
M1M23 cells (1,319 IMPs, 1.49 m2).
Fig. 7. High-magnification E-face images and companion diagrams illustrat-
ing 2-nm furrows linking adjacent pits. (A) Astrocyte square arrays with
missing furrows (arrow). (B) M23 raft has furrows connecting 90% of pits.
(C–E) Incipient arrays in M1 cells have fewer furrows and irregular lattice
spacings, ranging from 5 nm to 11 nm. (F) Square array in M1M23 cell has
furrows linking 50% of pits. All shadows are from right to left. Companion
diagrams denote positions of pits and furrows. Arrows indicate missing fur-
rows. B–E are shadowed at similar local declination angles and at 45°
azimuth to the orthogonal lattices; each was selected for identical platinum
granularity and image resolution. The effects of shadow angle and azimuth
on ability to resolve cross-bridges have been described (23). (450,000.)








immunoprecipitation to contain both M1 and M23 subunits.
Nevertheless, stoichiometry in brain and skeletal muscle showed
that M23 polypeptides outnumber M1 polypeptides by at least
3:1 (4, 5). M23 and M1 polypeptides are identical except the
22-residue peptide at the N terminus of M1. It is unknown how
this additional segment interferes with square array assembly,
because the atomic structures of homologous proteins did not
resolve N and C termini (20, 32–34).
The relevance of AQP4 square array assembly to the physi-
ology and pathophysiology of brain is unknown. Our studies
suggest that M1 and M23 may restrict AQP4 square array
assembly to a preferred size, but it is not clear why this is
important. AQP4 has a highly polarized distribution in brain. It
is greatly enriched in the perivascular membrane of astroglial
cells and at the glia limitans at brain surfaces (7, 8) and in retina
(9). AQP4 may release water from brain metabolism, and may
restore osmotic equilibrium during potassium siphoning after
high neuronal activity (11, 12). Recent studies indicate that
AQP4 is tethered at perivascular membranes by association with
dystrophin-associated proteins through an interaction with
-syntrophin (5, 12, 13, 35). A single linking protein could tether
a square array containing many AQP4 proteins to the cytoskel-
eton, whereas dispersed AQP4 tetramers might each require a
tether. Dissociation of square arrays may occur during cerebral
ischemia or other neural stress (14, 36). If dissociation of square
arrays needs to occur rapidly, organization of AQP4 into large
rafts may interfere with disassembly. Balancing the opposing
actions of M1 and M23 isoforms of AQP4 in astrocyte end-feet
may provide the optimal size of arrays for efficient tethering at
the perivascular membrane without impairing the ability to
rapidly disassemble.
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